Equities

Scisparc Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SPRC:NAQ

Scisparc Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.5973
  • Today's Change-0.016 / -2.56%
  • Shares traded93.77k
  • 1 Year change-94.63%
  • Beta1.2585
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2004
  • Employees2.00
  • Location
    Scisparc Ltd20 Raul Wallenberg Street, Tower ATEL AVIV-YAFO 6971916IsraelISR
  • Phone+972 36103100
  • Fax+972 36167056
  • Websitehttps://scisparc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Procyon Corp4.98m-312.97k1.53m19.00--0.7027--0.307-0.0387-0.03870.61380.28171.472.329.90262,338.40-10.081.19-12.701.4478.0774.40-6.840.86912.41--0.00--6.353.53-367.38--17.32--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
InVitro International716.89k6.22k1.67m16.00214.292.33--2.330.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
Panacea Life Sciences Holdings Inc2.76m-7.67m1.90m40.00------0.6858-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.122.58--46.59--12.33------
Universe Pharmaceuticals Inc17.86m-3.67m2.04m216.00--0.0363--0.1142-10.13-10.1339.1899.640.26025.881.3882,679.35-5.35-5.40-7.08-7.0935.2843.33-20.56-9.653.90-17.460.1416---22.44-10.2757.92--46.30--
Bio Essence Corp565.67k-160.45k2.08m2.00------3.67-0.0042-0.00420.0149-0.08161.26--16.06282,835.00-35.64-40.94----69.2838.36-28.36-134.00---57.42-------17.08-286.98------
SOHM Inc-100.00bn-100.00bn2.44m--------------------------------------------------------------
PRF Technologies Ltd0.00-4.09m2.51m2.000.01060.1526----301.27301.270.0020.970.00----0.00-57.27-71.03-118.06-84.02------------0.00-------56.12------
Scisparc Ltd-100.00bn-100.00bn2.67m2.00---------------1.46-----------63.15---90.87-------456.810.5151--1.04---54.64---22.69------
Jaguar Health Inc11.79m-40.29m2.75m49.00--0.7122--0.2337-54.06-54.0612.981.530.21840.20998.78240,510.20-76.04-90.27-152.77-144.3681.9275.33-348.22-458.250.5197-4.620.8759--19.7515.146.80------
Onconetix Inc1.22m-50.85m2.88m5.00--0.8557--2.35-350.74-350.742.142.160.031.3124.33244,750.00-120.44-82.49-240.72-114.7185.41---4,015.56-4,434.980.0706-17.940.0453--4,216.95---57.44--44.62--
China Pharma Holdings Inc4.05m-3.19m3.16m224.00--0.3796--0.7789-1.10-1.101.281.660.27692.1714.5218,090.54-21.80-18.69-35.67-37.95-10.94-1.14-78.72-44.960.1026-30.500.2884---35.41-16.15-53.84--16.49--
CYANOTECH CORP25.27m-1.78m3.36m83.00--0.416117.760.1328-0.2469-0.24693.511.091.052.2112.81304,433.80-7.41-6.08-13.42-8.0532.0032.26-7.03-6.370.2988-1.470.5089--4.96-5.3639.19--1.97--
Functional Brands Inc6.80m-377.56k3.53m32.00--2.53--0.5187-0.0546-0.05460.96140.08540.88730.352737.24212,408.80-4.93---9.96--91.06---5.55--0.4419-0.87230.6346---3.72--54.93------
Data as of Feb 12 2026. Currency figures normalised to Scisparc Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.58%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 31 Dec 202525.07k0.53%
BofA Securities, Inc.as of 30 Sep 20251.37k0.03%
UBS Switzerland AG (Investment Management)as of 31 Dec 2025622.000.01%
SBI Securities Co., Ltd.as of 31 Dec 202511.000.00%
Renaissance Technologies LLCas of 30 Sep 20250.000.00%
RhumbLine Advisers LPas of 30 Sep 20250.000.00%
Valley National Advisers, Inc.as of 31 Dec 20250.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.